5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2334 | Avanafil | TA1790 | PDE |
Avanafil (TA1790) is a selective inhibitor of phosphodiesterase type 5 (PDE5) and is used as therapy of erectile dysfunction. | |||
T37181 | Avanafil metabolite M4 | Avanafil metabolite M4 | |
Avanafil metabolite M4 is a major active metabolite of the phosphodiesterase 5 (PDE5) inhibitor avanafil . Avanafil is metabolized by the cytochrome P450 (CYP450) isoforms CYP3A4 and CYP2C to the major metabolites avanaf... | |||
T37180 | Avanafil metabolite M16 | ||
Avanafil metabolite M16 is a major inactive metabolite of the phosphodiesterase 5 (PDE5) inhibitor avanafil . Avanafil is metabolized by the cytochrome P450 (CYP450) isoforms CYP3A4 and CYP2C to the major metabolites ava... | |||
T83536 | (R)-Avanafil | (R)-TA1790 | |
(R)-Avanafil ((R)-TA1790) is a selective phosphodiesterase type 5 (PDE5) inhibitor with an IC50 of 5.2 nM, utilized for the research of erectile dysfunction [1]. | |||
T69432 | Avanafil dibesylate | ||
Avanafil dibesylate is a PDE5 inhibitor. |